Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Le Moing

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Neurology|July 2, 2008
Diagnostic approaches to imported schistosomal myeloradiculopathy in travelersA Makinson, R Juntas Morales, D Basset, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 6, 2001
The dynamic of adherence to highly active antiretroviral therapy: results from the French National APROCO cohortP Carrieri, V Cailleton, V Le Moing, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 13, 2016
Factors associated with 12 week case-fatality in Staphylococcus aureus bacteraemia: a prospective cohort studyP Braquet, F Alla, C Cornu, et al.
HIV Medicine|November 16, 2019
Potential lung cancer screening outcomes using different age and smoking thresholds in the ANRS-CO4 French Hospital Database on HIV cohortA Makinson, L Tron, S Grabar, et al.
AIDS (London, England)|August 26, 1998
Decreased prevalence of intestinal cryptosporidiosis in HIV-infected patients concomitant to the widespread use of protease inhibitorsV Le Moing, F Bissuel, D Costagliola, et al.
Infectious Diseases Now|February 1, 2021
COVID-19: The forgotten cases of hidden exilesC Le Bihan, V Faucherre, V Le Moing, et al.
HIV Medicine|April 28, 2007
Long-term evolution of CD4 count in patients with a plasma HIV RNA persistently <500 copies/mL during treatment with antiretroviral drugsV Le Moing, R Thiébaut, G Chêne, et al.
Neurology|November 18, 2009
HIV-related immune reconstitution cryptococcal meningoradiculitis: corticosteroid responseA S Brunel, A Brunel, A Makinson, et al.
Antimicrobial Agents and Chemotherapy|November 18, 2000
Hepatitis B or hepatitis C virus infection is a risk factor for severe hepatic cytolysis after initiation of a protease inhibitor-containing antiretroviral regimen in human immunodeficiency virus-infected patients. The APROCO Study GroupM Savès, F Raffi, P Clevenbergh, et al.
Annales De Medecine Interne|March 10, 2001
[Long-term immunologic response in HIV-infected patients with CD4 cell counts </= 50/mm3 when initiating protease inhibitor therapy]V Le Moing, Z Eid, J L Ecobichon, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Neurology|July 2, 2008
Diagnostic approaches to imported schistosomal myeloradiculopathy in travelersA Makinson, R Juntas Morales, D Basset, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 6, 2001
The dynamic of adherence to highly active antiretroviral therapy: results from the French National APROCO cohortP Carrieri, V Cailleton, V Le Moing, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 13, 2016
Factors associated with 12 week case-fatality in Staphylococcus aureus bacteraemia: a prospective cohort studyP Braquet, F Alla, C Cornu, et al.
HIV Medicine|November 16, 2019
Potential lung cancer screening outcomes using different age and smoking thresholds in the ANRS-CO4 French Hospital Database on HIV cohortA Makinson, L Tron, S Grabar, et al.
AIDS (London, England)|August 26, 1998
Decreased prevalence of intestinal cryptosporidiosis in HIV-infected patients concomitant to the widespread use of protease inhibitorsV Le Moing, F Bissuel, D Costagliola, et al.
Infectious Diseases Now|February 1, 2021
COVID-19: The forgotten cases of hidden exilesC Le Bihan, V Faucherre, V Le Moing, et al.
HIV Medicine|April 28, 2007
Long-term evolution of CD4 count in patients with a plasma HIV RNA persistently <500 copies/mL during treatment with antiretroviral drugsV Le Moing, R Thiébaut, G Chêne, et al.
Neurology|November 18, 2009
HIV-related immune reconstitution cryptococcal meningoradiculitis: corticosteroid responseA S Brunel, A Brunel, A Makinson, et al.
Antimicrobial Agents and Chemotherapy|November 18, 2000
Hepatitis B or hepatitis C virus infection is a risk factor for severe hepatic cytolysis after initiation of a protease inhibitor-containing antiretroviral regimen in human immunodeficiency virus-infected patients. The APROCO Study GroupM Savès, F Raffi, P Clevenbergh, et al.
Annales De Medecine Interne|March 10, 2001
[Long-term immunologic response in HIV-infected patients with CD4 cell counts </= 50/mm3 when initiating protease inhibitor therapy]V Le Moing, Z Eid, J L Ecobichon, et al.
Pageof 6